Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon- α

Digestive Diseases and Sciences

Volumn 45, Issue 1, 2000, Pages 175-181

  Trimoulet, Pascale ^a   Bernard, Pierre Henri ^a   De Ledinghen, Victor ^a   Oui, Benoit ^a   Chene, Genevieve ^a   Girardin, Marie France Saint Marc ^a   Dantin, Sylvie ^a   Couzigou, Patrice ^a   Fleury, Herve ^a,b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Cells; Hepatitis C virus; Interferon; Quantitation; RNA; Treatment

Indexed keywords

ALPHA2A INTERFERON; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS LOAD; VIRUS TITRATION;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, VIRAL; TIME FACTORS; VIRAL LOAD;

EID: 0033995355     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005490100842     Document Type: Article

References (33)

1. 1. Chou QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362, 1989
2. 2. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW: Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Br Med Bull 46:423-441, 1990
3. 3. Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo QL, Kuo G: Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for post-transfusion hepatitis. Proc Natl Acad Sci USA 87:983-987, 1990
4. 4. Zignego AL, Macchia D, Monti M, Thicrs V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C: Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15:382-386, 1992
5. 5. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB: Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 166:1276-1280, 1992
6. 6. Qian C, Camps J, Maluenda MD, Civeira MP, Prieto J: Replication of hepatitis C virus in peripheral blood mononuclcar cells. Effect of alpha-interferon therapy. J Hepatol 16:380-383, 1992
7. 7. Hsieh T, Yao D, Sheen I, Liaw Y, Pao CC: Hepatitis C virus in peripheral blood mononuclear cells. Am J Clin Pathol 98:392-396, 1992
8. 8. Muller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L: Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 74:669-676, 1993
9. 9. Chang T-T, Young K-C, Yang Y-J, Lei H-Y, Wu H-L: Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection. Hepatology 23:977-981, 1996
10. 10. Saleh MG, Tibbs CJ, Koskinas J, Pereira LMMB, Bomford AB, Portmann BC, McFarlane IG, Williams R: Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy. Hepatology 20:1399-1404, 1994
11. 11. Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, Reynes M, Maisonneuve P, Bismuth H, Brechot C: Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 89:1361-1365, 1992
12. 12. Radkowski M, Wang LF, Vargas HE, Rakela J, Laskus T: Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation 66:664-666, 1998
13. 13. Hoofnagle JH, Di Bisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 336:347-356, 1997
14. 14. Tine F, Magrin S, Craxi A, Pagliaro L: Interferon for non-A, non-B chronic hepatitis: a meta-analysis of randomised clinical trials. J Hepatol 13:192-199, 1991
15. 15. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payen JL, Sajus M, Costa JM: A comparison of three Interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457-1462, 1995
16. 16. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP: Meta-analysis of Interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. Hepatology 24:778-789, 1996
17. 17. Lin R, Roach E, Zimmerman M, Strasser S, Farrell GC: Interferon alfa-2b for chronic hepatitis C: Effects of dose increment and duration of treatment on response rates: results of the first multicentre Australian trial. J Hepatol 23:487-496, 1995
18. 18. Carithers RL Jr, Emerson SS: Therapy of hepatitis C: Meta-analysis of Interferon alfa-2b trials. Hepatology 26 (Suppl 1):83S-88S, 1997
19. 19. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group: An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24:289-293, 1996
20. 20. Stuyver L, Rossan R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G: Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093-1102, 1993
21. 21. Simmonds P, Alberti A, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS: A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324, 1994
22. 22. Lau JY, Davis GL, Kniffen J, Quian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC: Significance of serum hepatitis C virus RNA levels in chronic hepatitis. Lancet 341:1501-1504, 1993
23. 23. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S: Pretreatment HCV RNA levels and HCV genotype are the main and independent prognostic factors of sustained response to alpha interferon therapy in chronic hepatitis C. Hepatology 22:1050-1056, 1995
24. 24. Pawlotsky JM, Roudot-Thoraval F, Bastie A, Darthuy F, Rémiré J, Métreau JM, Zafrani E, Duval J, Dhumeaux D: Factors affecting treatment responses to interferon-α in chronic hepatitis C. J Infect Dis 174:1-7, 1996
25. 25. Peerlinck K, Willems M, Sheng L, Nevens F, Fevery J, Yap SH, Vermylen J: Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with α-2b interferon is not a predictor for sustained response to treatment. Br J Haematol 86:816-819, 1994
26. 26. Gil B, Qian C, Riezu-Boj JI. Civeira MP, Preito J: Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: Different patterns of response to interferon treatment. Hepatology 18:1050-1054, 1993
27. 27. Ounanian A, Gueddah N, Rolachon A, Thelu MA, Zarski JP, Seigneurin JM: Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha interferon. J Med Virol 45:141-145, 1995
28. 28. Kusaka S, Okusa T, Araki A, Fujiki K, Takashimizu I, Okayasu I, Yamamoto N, Sato C: Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells. J Med Virol 46:265-268, 1995
29. 29. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JY: Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol 46:109-115, 1995
30. 30. Hino K, Okuda M, Konishi T, Ishiko H, Okita K: Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig Dis Sci 40:14-20, 1995
31. 31. Karino Y, Toyota J, Sugawara M, Higashino K, Sato T, Ohmura T, Suga T, Okuuchi Y, Matsushima T: Early loss of serum hepatitis C virus RNA can predict a sustained response to Interferon therapy in patients with chronic hepatitis C. Am J Gastroenterol 92:61-65, 1997
32. 32. Gavier B, Martinez-Gonzalez MA, Riezu-Boj JI, Lasarte JJ, Garcia N, Civeira MP, Prieto J: Viremia after one month of Interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology 113:1647-1653, 1997
33. 33. Izopet J, Payen JL, Alric L, Sandres K, Charlet JP, Vinel JP, Duffaut M, Pascal JP, Puel J: Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy. J Med Virol 54:86-91, 1998